These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

150 related articles for article (PubMed ID: 5606372)

  • 21. [Combination of tetracycline and pancreatic proteolytic enzymes in the therapy of gynecologic inflammation].
    Rusca F; Perone N
    Praxis; 1969 Apr; 58(17):556-9. PubMed ID: 5819044
    [No Abstract]   [Full Text] [Related]  

  • 22. The practicing physician, the tuberculin reactor and isoniazid.
    Edson RC
    Conn Med; 1971 Apr; 35(4):233-6. PubMed ID: 5550907
    [No Abstract]   [Full Text] [Related]  

  • 23. [Isoniazide-tiocarlide combination or DAT in the treatment of pulmonary tuberculosis. Comparison with isoniazide-PAS combination and especially BPAS].
    Meyer A; Nadjar-Fossé G
    Rev Tuberc Pneumol (Paris); 1968; 32(3):371-80. PubMed ID: 5693998
    [No Abstract]   [Full Text] [Related]  

  • 24. [Treatment of pulmonary tuberculosis with a combination of long-acting isoniazid inhalation and pyridoxine].
    Uhde H
    Prax Pneumol; 1965 Nov; 19(11):696-701. PubMed ID: 5884179
    [No Abstract]   [Full Text] [Related]  

  • 25. Lamivudine enabled isoniazid and rifampicin treatment in pulmonary tuberculosis and hepatitis B co-infection.
    Yu WC; Lai ST; Chiu MC; Chau TN; Ng TK; Tam CM
    Int J Tuberc Lung Dis; 2006 Jul; 10(7):824-5. PubMed ID: 16850548
    [No Abstract]   [Full Text] [Related]  

  • 26. [Results of treatment of newly detected pulmonary tuberculosis with rifampin combined with isoniazid and ethambutol].
    Szymański A; Walecki J; Czaplińska-Jóźwiak E; Kuczborska Z; Gaik A; Bilczak Z; Swiatnicka I; Swica T; Zdawski T
    Pneumonol Pol; 1980 Nov; 48(11):669-74. PubMed ID: 7255207
    [No Abstract]   [Full Text] [Related]  

  • 27. [Intramuscular administration of combined trypsin and chymotrypsin in therapy of thrombophlebitis of obstetric and gynecological origin].
    LURASCHI C
    Riv Ostet Ginecol Prat; 1957 Dec; 39(12):1163-91. PubMed ID: 13528759
    [No Abstract]   [Full Text] [Related]  

  • 28. [Effect of corticotherapy on the residual pulmonary lesions after antitubercular chemotherapy].
    Araszkiewicz W
    Gruzlica; 1969 Mar; 37(3):223-34. PubMed ID: 5814946
    [No Abstract]   [Full Text] [Related]  

  • 29. [Effect of simultaneous administration of 5-bromosalicylhydroxamic acid (T40) and INH on the concentration of free INH in urine of tubercular patients].
    Zduńczyk-Pawelek H; Otrzonsek N; Kostrzewska K
    Z Tuberk Erkr Thoraxorg; 1965; 124(3):149-52. PubMed ID: 5899137
    [No Abstract]   [Full Text] [Related]  

  • 30. [Clinical contribution on a case of tuberculous ulcer caused by a costal lesion treated with proteolytic enzymes by topical administration in association with chemio-antibiotic agents].
    TODOROFF T; BRAGHIERI B
    G Ital Tuberc Mal Torace; 1962; 16():270-6. PubMed ID: 13985259
    [No Abstract]   [Full Text] [Related]  

  • 31. [Enzymatic therapy in the overall treatment of the initial forms of mastitis].
    Tambiev EI
    Vopr Okhr Materin Det; 1977 Dec; 22(12):66-7. PubMed ID: 341511
    [No Abstract]   [Full Text] [Related]  

  • 32. [Clinical test of an antibiotic-enzyme combination in dentistry].
    Monteverde J
    Rev Circ Argent Odontol; 1969 May; 32(2):47-8. PubMed ID: 5256788
    [No Abstract]   [Full Text] [Related]  

  • 33. The clearance of theophylline is increased during the initial period of tuberculosis treatment.
    Ahn HC; Lee YC
    Int J Tuberc Lung Dis; 2003 Jun; 7(6):587-91. PubMed ID: 12797703
    [TBL] [Abstract][Full Text] [Related]  

  • 34. [Controlled clinical studies on the mucoproteolytic action of a lysozyme-trypsin-chymotrypsin association in the phlogoses of the bronchial tree].
    Piazza G
    G Ital Mal Torace; 1972; 26(1):45-52. PubMed ID: 5052574
    [No Abstract]   [Full Text] [Related]  

  • 35. [The therapeutic value of combined trypsin and alphachymotrypsin in otorhinolaryngology].
    Foissin B; Ohanian D; Yana M
    Rev Laryngol Otol Rhinol (Bord); 1965; 86(3):281-9. PubMed ID: 5828860
    [No Abstract]   [Full Text] [Related]  

  • 36. [Isoniazid-H3 distribution in a tubercular focus in the wall of a pulmonary cavern in rats].
    Cherednichenko LP
    Probl Tuberk; 1969; 47(5):80-5. PubMed ID: 5367976
    [No Abstract]   [Full Text] [Related]  

  • 37. The use of a trypsin-chymotrypsin formulation in fractures of the hand.
    Shaw PC
    Br J Clin Pract; 1969 Jan; 23(1):25-6. PubMed ID: 4884206
    [No Abstract]   [Full Text] [Related]  

  • 38. [Comparison of efficiency of large and small doses of isoniazid in combined treatment in pulmonary tuberculosis].
    Mysakowska H; Grodzki S; Przemyska B; Szarewicz W; Srednicka D
    Pol Tyg Lek; 1965 Apr; 20(16):562-4. PubMed ID: 5834844
    [No Abstract]   [Full Text] [Related]  

  • 39. Study of drug resistance in previously treated tuberculosis patients in Gujarat, India.
    Shah AR; Agarwal SK; Shah KV
    Int J Tuberc Lung Dis; 2002 Dec; 6(12):1098-101. PubMed ID: 12546118
    [TBL] [Abstract][Full Text] [Related]  

  • 40. [Therapeutic effect of combining trypsin-chimotrypsin and acetyl-salicylic acid in dentistry].
    Fraysse E; Fraysse-Puzin H
    Rev Odontoimplantol; 1967 Nov; 9():49-51. PubMed ID: 5236965
    [No Abstract]   [Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 8.